{"id":3929,"date":"2017-08-12T17:32:47","date_gmt":"2017-08-12T17:32:47","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/esho-2024-andromedic\/"},"modified":"2026-02-17T08:45:12","modified_gmt":"2026-02-17T08:45:12","slug":"esho-2024-andromedic","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/et\/esho-2024-andromedic\/","title":{"rendered":"ESHO 2024 Andromedic"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"WebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/esho-2024-andromedic\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/et\/esho-2024-andromedic\/\",\n      \"name\": \"ESHO 2024 M\u00e1laga: Andromedic & SIIO teaduslikud \u00fclevaated\",\n      \"description\": \"Teaduslikud \u00fclevaated ESHO 2024 M\u00e1laga kongressilt. Andromedic esitleb SIIO abstrakti onkoloogilise h\u00fcpertermia arengust.\",\n      \"inLanguage\": \"et-EE\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \/* MASTER GRAPH LINK *\/\n      \"about\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" }\n    },\n    {\n      \"@type\": \"MedicalScholarlyArticle\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/et\/esho-2024-andromedic\/#article\",\n      \"headline\": \"Itaalia Onkoloogilise H\u00fcpertermia Selts (SIIO): asutamine, tegevused ja tulevikuprojektid\",\n      \"author\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" }\n      ],\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \/* MAIN KEYWORD SYNC: HyDeep 600WM *\/\n      \"keywords\": \"ESHO 2024, onkoloogiline h\u00fcpertermia, SIIO, SRHO, HyDeep 600WM\",\n      \"about\": [\n         { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n         { \"@id\": \"https:\/\/andromedichyperthermia.com\/#srho\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"T\u00e4iustatud onkoloogiline h\u00fcpertermia s\u00fcsteem \/ moduleeritud raadiosageduslik (RF) h\u00fcpertermia seade.\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/et\/contact\/\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Hind n\u00f5udmisel\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Tipptasemel s\u00fcvahipertermia tehnoloogia kliiniliselt valideeritud protokollidega.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Roboto, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"text-align: center; margin-bottom: 40px;\">\n<h1 style=\"color: #1a2a6c; font-size: 36px; font-weight: 800; margin-bottom: 10px;\">Euroopa H\u00fcpertermilise Onkoloogia Seltsi kongress<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 24px; font-weight: 600; margin-top: 0;\">ESHO 2024 M\u00e1laga | T\u00e4iustatud onkoloogiline h\u00fcpertermia s\u00fcsteem<\/h2>\n<\/header>\n<div style=\"margin-bottom: 30px; text-align: center;\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"533\" class=\"size-full wp-image-522\" style=\"width: 100%; border-radius: 12px; box-shadow: 0 10px 25px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-scaled.jpg\" alt=\"ESHO 2024 Malaga Hispaania - HyDeep 600WM onkoloogiline h\u00fcpertermia s\u00fcsteem\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-scaled.jpg 2560w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-300x63.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-1024x213.jpg 1024w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-768x160.jpg 768w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-1536x320.jpg 1536w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO2024-Banner-Startseite-2048x427.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p style=\"font-size: 13px; color: #777; margin-top: 10px;\">ESHO 2024 &#8211; M\u00e1laga, Hispaania: Termoteraapia tuleviku tutvustamine.<\/p>\n<\/div>\n<section style=\"background: #f8f9fa; padding: 25px; border-radius: 12px; margin-bottom: 40px; border-left: 6px solid #1a2a6c;\">\n<p style=\"font-size: 18px; margin: 0; text-align: center;\"><strong>Andromedicu meeskond<\/strong>, keda esindasid <a style=\"color: #1a2a6c; font-weight: bold; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\">dr Salvatore Conte<\/a> ja <a style=\"color: #1a2a6c; font-weight: bold; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/ciro-zaccagnini-ceo\/\">Ciro Zaccagnini (tegevjuht)<\/a>, osales j\u00e4rgmisel \u00fcritusel:<\/p>\n<h3 style=\"text-align: center; font-size: 22px; margin-top: 15px;\"><a style=\"color: #b21f1f; text-decoration: underline;\" href=\"https:\/\/esho-congress.eu\/\" target=\"_blank\" rel=\"noopener\">Euroopa H\u00fcpertermilise Onkoloogia Seltsi 36. aastakoosolek (ESHO 2024)<\/a><\/h3>\n<\/section>\n<div style=\"text-align: center; margin-bottom: 50px;\"><img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"1333\" class=\"size-full wp-image-50\" style=\"width: 100%; max-width: 900px; border-radius: 10px; border: 1px solid #eee;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc.jpg\" alt=\"Andromedicu meeskond ESHO 2024 kongressil - HyDeep 600WM lokaalne s\u00fcvah\u00fcpertermia seade\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc.jpg 2000w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc-300x200.jpg 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc-768x512.jpg 768w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/ESHO_2024_-_Andromedic-team-OncoTherm-team-etc-1536x1024.jpg 1536w\" sizes=\"auto, (max-width: 2000px) 100vw, 2000px\" \/><\/p>\n<p style=\"font-size: 13px; color: #777; margin-top: 10px;\">ESHO 2024 &#8211; Andromedicu meeskond, OncoThermi meeskond ja rahvusvahelised koost\u00f6\u00f6partnerid.<\/p>\n<\/div>\n<article style=\"background: #fff; border: 1px solid #e1e8ed; border-radius: 15px; padding: 40px; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<h2 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; padding-bottom: 15px; margin-bottom: 25px; font-size: 26px;\">Esitletud teaduslik kokkuv\u00f5te<\/h2>\n<h3 style=\"font-size: 22px; color: #b21f1f; line-height: 1.4; margin-bottom: 20px;\">Itaalia Onkoloogilise H\u00fcpertermia Selts (SIIO): asutamine, tegevused ja tulevikuprojektid termoteraapia ja h\u00fcpertermia arendamiseks Itaalias<\/h3>\n<div style=\"background: #fdfdfd; padding: 20px; border-radius: 8px; margin-bottom: 30px; font-size: 15px;\"><strong>Autorid:<\/strong> G. Fiorentini<sup>1<\/sup>, G. Ranieri<sup>2<\/sup>, M. Bonucci<sup>3<\/sup>, S. Bonanno<sup>4<\/sup>, G. Cristina<sup>5<\/sup>, R. Lodico<sup>6<\/sup>, D. Sarti<sup>7<\/sup><\/p>\n<ol style=\"font-size: 13px; color: #666; line-height: 1.5;\">\n<li>San Salvatore haigla, onkoloogia, Pesaro, Itaalia<\/li>\n<li>Riiklik V\u00e4hivastane Instituut, onkoloogia, Bari, Itaalia<\/li>\n<li>ARTOI sihtasutus, integratiivne onkoloogia, Rooma, Itaalia<\/li>\n<li>Regionaalhaigla, radioteraapia, S\u00fcrakuusa, Itaalia<\/li>\n<li>Regionaalhaigla, sisehaigused &#8211; komplementaarne meditsiin, Merano, Itaalia<\/li>\n<li>San Camillo Forlanini, kirurgiline onkoloogia, Rooma, Itaalia<\/li>\n<li>Onkoloogia\u00fcksus, Urbino, Itaalia<\/li>\n<\/ol>\n<\/div>\n<div style=\"font-size: 16px; line-height: 1.8; color: #444;\"><strong>Itaalia Onkoloogilise H\u00fcpertermia Selts (SIIO)<\/strong> asutati 2023. aasta septembris, et edendada onkoloogilist h\u00fcpertermiat Itaalias ja arendada seda riiklikul tasandil, eesm\u00e4rgiga pakkuda v\u00e4hipatsientidele paremat ravi.<\/p>\n<h4 style=\"color: #1a2a6c; margin-top: 25px;\">Metoodika<\/h4>\n<p>SIIO on t\u00e4naseks kaasanud 20 keskust, sealhulgas riiklikud haiglad ja erakliinikud. K\u00f5ik h\u00fcpertermiakeskused on n\u00f5ustunud SIIO p\u00f5hikirja ja eetikakoodeksiga. Heaks kiideti ja esitati j\u00e4rgmised teemad:<\/p>\n<ul style=\"padding-left: 20px;\">\n<li>Teadmiste levitamine <strong>termoteraapia<\/strong> ja seotud valdkondade kohta publikatsioonide, kohtumiste ja koolituss\u00fcmpoosionide kaudu.<\/li>\n<li>H\u00fcpertermia arengu soodustamine k\u00f5igis arstiteaduse valdkondades.<\/li>\n<li>Koost\u00f6\u00f6 edendamine <strong>f\u00fc\u00fcsika, inseneriteaduste, bioloogia, keemia ja meditsiini<\/strong> vahel, et uurida h\u00fcpertermia omadusi ja m\u00f5ju meditsiinis, sealhulgas j\u00e4semete ja siseelundite h\u00fcpertermiline perfusioon, laserravi ja raadiosageduslik ablatsioon.<\/li>\n<li>Riikliku andmebaasi loomine h\u00fcpertermiaga ravitud kasvajate kohta: t\u00fc\u00fcp, staadium, raviskeem, tulemused, toksilisus ja elulemus.<\/li>\n<li>Uute <strong>integreeritud protokollide (II ja III faas)<\/strong> m\u00e4\u00e4ratlemine kemo-h\u00fcpertermia, radio-h\u00fcpertermia, immuun-h\u00fcpertermia ja palliatiivse h\u00fcpertermia jaoks.<\/li>\n<\/ul>\n<h4 style=\"color: #1a2a6c; margin-top: 25px;\">Tulemused<\/h4>\n<p>Esialgsete andmete t\u00f6\u00f6tlemine on pooleli. Itaalias ravitakse h\u00fcpertermiaga igal aastal umbes <strong>kolm tuhat patsienti<\/strong> (86% erakliinikutes, 14% riiklikes haiglates), kes k\u00f5ik on metastaatilises faasis ja retsidiveerunud p\u00e4rast keemia- ja kiiritusravi, oodatava elueaga 3 kuni 24 kuud.<\/p>\n<p>Iga patsient sai keskmiselt <strong>\u00fcksteist h\u00fcpertermia seanssi<\/strong> (vahemikus 3\u201328), kasutades erinevaid h\u00fcpertermia seadmeid: <strong>Andromedic (HyDeep 600WM)<\/strong>, Oncotherm, BSD, Celsius, Syncrotherm. Ravi kestus oli 55 minutit, sagedusega 2\u20133 seanssi n\u00e4dalas. 50% patsientidest sai individuaalset keemiaravi ja 90% sai integratiivset toetavat ravi. Erilist t\u00e4helepanu p\u00f6\u00f6rati patsientide elukvaliteedi parandamise hindamisele <strong>ESAS-skaala<\/strong> abil.<\/p>\n<h4 style=\"color: #1a2a6c; margin-top: 25px;\">J\u00e4reldused<\/h4>\n<p>SIIO eesm\u00e4rk on laiendada ravis\u00fcsteemi, suurendades h\u00fcpertermiakeskuste arvu ning koolitades v\u00e4lja asjatundlikke arste, tehnikuid ja \u00f5desid. SIIO kavatseb teha koost\u00f6\u00f6d <strong>Itaalia terviseministeeriumi<\/strong> ja meditsiini\u00fchingutega, et pakkuda t\u00f5est teavet ja optimeerida kulusid, h\u00f5lbustades patsientide juurdep\u00e4\u00e4su **moduleeritud raadiosageduslikule h\u00fcpertermia s\u00fcsteemile** kogu riigis ja Euroopas.<\/p>\n<\/div>\n<\/article>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Euroopa H\u00fcpertermilise Onkoloogia Seltsi kongress ESHO 2024 M\u00e1laga | T\u00e4iustatud onkoloogiline h\u00fcpertermia s\u00fcsteem ESHO 2024 &#8211; M\u00e1laga, Hispaania: Termoteraapia tuleviku tutvustamine. Andromedicu meeskond, keda esindasid dr Salvatore Conte ja Ciro Zaccagnini (tegevjuht), osales j\u00e4rgmisel \u00fcritusel: Euroopa H\u00fcpertermilise Onkoloogia Seltsi 36. aastakoosolek (ESHO 2024) ESHO 2024 &#8211; Andromedicu meeskond, OncoThermi meeskond ja rahvusvahelised koost\u00f6\u00f6partnerid. Esitletud teaduslik&hellip;<\/p>\n","protected":false},"author":1,"featured_media":2693,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-3929","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/comments?post=3929"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/pages\/3929\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/media\/2693"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/et\/wp-json\/wp\/v2\/media?parent=3929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}